Comparison of mealtime pramlintide, insulin, or a combination of both, when added to basal insulin treatment in patients with type 2 diabetes

被引：0
|
作者：
Karounos, D. [1 ,2 ]
Pencek, R. [3 ]
Huang, W. [3 ]
Miller, S. [3 ]
Lutz, K. [3 ]
Porter, L. [3 ]
机构：
[1] Lexington VA Med Ctr, Lexington, VA USA
[2] Univ Kentucky, Coll Med, Lexington, KY USA
[3] Amylin Pharmaceut Inc, San Diego, CA USA
来源：
DIABETOLOGIA | 2009年 / 52卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
912
引用
收藏
页码：S358 / S358
页数：1
相关论文
共 50 条
  • [41] Comparison of oral insulin spray and subcutaneous regular insulin at mealtime in type I diabetes
    Guevara-Aguirre, Jaime
    Guevara-Aguirre, Marco
    Saavedra, Jeannette
    Bernstein, Gerald
    Rosenbloom, Arlan L.
    [J]. DIABETES TECHNOLOGY & THERAPEUTICS, 2007, 9 (04) : 372 - 376
  • [42] Safety and efficiency of the combination of basal insulin with liraglutide in hospitalised patients with type 2 diabetes
    Papantoniou, S.
    [J]. DIABETOLOGIA, 2020, 63 (SUPPL 1) : S289 - S289
  • [43] Improved glucose control with reduced hypoglycaemic risk when linagliptin is added to basal insulin in elderly patients with type 2 diabetes
    Inzucchi, S. E.
    Nauck, M. A.
    Hehnke, U.
    Woerle, H-J.
    von Eynatten, M.
    Henry, R. R.
    [J]. DIABETES OBESITY & METABOLISM, 2015, 17 (09): : 868 - 877
  • [44] Basal insulin requirement in insulin treated patients with type 2 diabetes mellitus
    Wiesli, P
    Lehmann, R
    Kraydenbühl, PA
    Schmid, C
    Spinas, GA
    [J]. DIABETES, 2005, 54 : A102 - A102
  • [45] A STEPWISE APPROACH TO INSULIN THERAPY IN PATIENTS WITH TYPE 2 DIABETES MELLITUS AND BASAL INSULIN TREATMENT FAILURE
    Davidson, Mayer B.
    Raskin, Philip
    Tanenberg, Robert J.
    Vlajnic, Aleksandra
    Hollander, Pricilla
    [J]. ENDOCRINE PRACTICE, 2011, 17 (03) : 395 - 403
  • [46] Switching From Insulin Bolus Treatment to GLP-1 RAs Added to Continued Basal Insulin in People With Type 2 Diabetes on Basal-Bolus Insulin
    Bolli, Geremia B.
    Porcellati, Francesca
    Meier, Juris J.
    [J]. DIABETES CARE, 2020, 43 (10) : 2333 - 2335
  • [47] Comparison of glycaemic control in patients with Type 2 diabetes on basal insulin and fixed combination oral antidiabetic treatment: results of a pilot study
    G. De Mattia
    O. Laurenti
    A. Moretti
    [J]. Acta Diabetologica, 2009, 46
  • [48] Comparison of glycaemic control in patients with Type 2 diabetes on basal insulin and fixed combination oral antidiabetic treatment: results of a pilot study
    De Mattia, G.
    Laurenti, O.
    Moretti, A.
    [J]. ACTA DIABETOLOGICA, 2009, 46 (01) : 67 - 73
  • [49] An indirect treatment comparison of the efficacy of insulin degludec/liraglutide (IDegLira) and insulin glargine/lixisenatide (iGlarLixi) in patients with type 2 diabetes uncontrolled on basal insulin
    Evans, Marc
    Billings, Liana K.
    Hakan-Bloch, Jonas
    Slothuus, Ulla
    Abrahamsen, Trine J.
    Andersen, Andreas
    Jansen, Jeroen P.
    [J]. JOURNAL OF MEDICAL ECONOMICS, 2018, 21 (04) : 340 - 347
  • [50] Initiation and Gradual Intensification of Premixed Insulin Lispro Therapy Versus Basal ± Mealtime Insulin in Patients With Type 2 Diabetes Eating Light Breakfasts
    Giugliano, Dario
    Tracz, Mariusz
    Shah, Sanjiv
    Calle-Pascual, Alfonso
    Mistodie, Cristina
    Duarte, Rui
    Sari, Ramazan
    Woo, Vincent
    Jiletcovici, Alina O.
    Deinhard, Juergen
    Wille, Simone A.
    Kiljanski, Jacek
    [J]. DIABETES CARE, 2014, 37 (02) : 372 - 380
12345